When an unblinded clinician rates a self-limiting condition in a cohort that has already lost a quarter of its patients, a near-universal response rate is close to the expected result whether or not the drug does anything
Therefore, not only CVOTs, but also HF, kidney and metabolic outcomes trials have been conducted with the new T2D medications
For an additional 127 people with both obesity and type 2 diabetes, the average weight loss over the year was 8.4 to 12.3 percent of body weight, compared to 1.7 percent for those given placebo treatments
By eating more protein at the start of each meal, people can effectively suppress appetite
PlexusDx supports your treatment with accessible pricing (no membership, no insurance required) and HSA/FSA eligibility to remove financial barriers to sustained therapy, which is the real driver of cumulative weight loss